Status:
COMPLETED
Place of Birth and Neonatal Health in Cases of Premature Birth Between 32 and 36 Weeks of Amenorrhoea
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Premature Between 32 and 36 Weeks of Amenorrhoea
Eligibility:
All Genders
Brief Summary
Moderate and late premature babies (32-36 weeks of amenorrhoea) account for around 6% of births, but 20% of neonatal deaths. These children also have an increased risk of neonatal morbidity and long-t...
Eligibility Criteria
Inclusion
- All mothers and their newborn babies (live or stillborn) who had a delivery stay between 32 and 36 days of age recorded in the PMSI between 01/01/2015 and 31/12/2020.
Exclusion
- Births in very small maternity units
- Births in hospitals without an obstetrics unit
- Births outside hospitals.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
240000 Patients enrolled
Trial Details
Trial ID
NCT06078618
Start Date
January 1 2022
End Date
March 31 2023
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000